Adriamycin-incorporated nanoparticles of deoxycholic acid-conjugated dextran: antitumor activity against CT26 colon carcinoma.

@article{Park2011AdriamycinincorporatedNO,
  title={Adriamycin-incorporated nanoparticles of deoxycholic acid-conjugated dextran: antitumor activity against CT26 colon carcinoma.},
  author={Kwang Bum Park and Young-Li Jeong and Ki Choon Choi and Su Gwan Kim and Hak Kyun Kim},
  journal={Journal of nanoscience and nanotechnology},
  year={2011},
  volume={11 5},
  pages={4240-9}
}
In this study, we prepared adriamycin (ADR)-encapsulated nanoparticles using deoxycholic acid-conjugated dextran (DexDA). Its antitumor activity was evaluated using CT 26 tumor cells in vitro and in vivo. ADR-incorporated DexDA nanoparticles have spherical shapes and their particle sizes were ranged about 50-200. Their particle sizes were changed according… CONTINUE READING